ADME 독성 시험 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The ADME Toxicology Testing Market size is expected to reach USD 18.30 Billion in 2034 from USD 7.55 Billion (2025) growing at a CAGR of 10.34% during 2026-2034.

The Global ADME (Absorption, Distribution, Metabolism, and Excretion) Toxicology Testing Market has grown steadily due to rising pharmaceutical R&D activities. Drug developers rely on ADME testing to assess safety and efficacy before clinical trials. Regulatory requirements for drug approval further stimulate demand.

Key drivers include increasing investment in biotechnology, expanding pipeline drugs, and technological advancements in in-vitro testing methods. Contract research organizations (CROs) play a significant role in providing specialized testing services. Growing focus on reducing late-stage drug failures supports market growth.

Future prospects remain strong with innovations in predictive modeling and AI-assisted toxicology testing. Personalized medicine and biologics development will increase testing requirements. Expansion of pharmaceutical industries in emerging economies is expected to further accelerate growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Cell Culture Tech
• High Throughput Tech
• Molecular Imaging Tech
• OMICS Technology

By Method Provider

• Cellular Assay
• Biochemical Assay
• In-Silica
• Ex-vivo

By Application

• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Other Toxicities

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Danaher, Charles River Laboratories, Promega Corporation, Agilent Technologies Inc, Curia Global Inc, Dassault Systmes, Catalent Inc, Labcorp, Eurofins Scientific, Miltenyi Biotec, IQVIA Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ADME TOXICOLOGY TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Cell Culture Tech Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. High Throughput Tech Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Molecular Imaging Tech Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. OMICS Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ADME TOXICOLOGY TESTING MARKET: BY METHOD PROVIDER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Method Provider
• 5.2. Cellular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biochemical Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. In-Silica Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Ex-vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ADME TOXICOLOGY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Systemic Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Renal Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hepatotoxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Neurotoxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Toxicities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ADME TOXICOLOGY TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Method Provider
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Method Provider
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Method Provider
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Method Provider
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Method Provider
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ADME TOXICOLOGY TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Danaher
  • 9.2.3 Charles River Laboratories
  • 9.2.4 Promega Corporation
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Curia Global Inc
  • 9.2.7 Dassault SystAfA¨Mes
  • 9.2.8 Catalent Inc
  • 9.2.9 Labcorp
  • 9.2.10 Eurofins Scientific
  • 9.2.11 Miltenyi Biotec
  • 9.2.12 IQVIA Inc